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Psilocin
2-6) (1a, Chart 1) and psilocybin 2) (1b) are well known indole alkaloids which cause powerful psychotomimetic effect. 2) With an aim to carry out their structure-activity relationship studies, several efforts have thus far been reported. 3, 4) In 1959, Hofmann and co-workers, 3) and in 1985, Repke and co-workers 4) had undertaken syntheses of psilocin analogs. Their interests were focused mainly on the modification of the side chain at the 3-position of 1a. As a result, various compounds shown in a general formula 2 were produced. However, to our knowledge, no reports are known about the modification on the benzene part of indole nucleus of 1a.
With an expectation that suitable lead compounds for psychotic diseases, such as depression, schizophrenia, Alzheimer's disease, and so on, could be discovered among psilocin derivatives and analogs, we have created a simple preparative method 5) for 1a in 50% overall yield as shown in Chart 1 in 1998. Since then, two groups have reported another synthetic methods for 1a. 6) Our synthesis of 1a consists of only five steps from indole-3-carbaldehyde (3) through 4-benzyloxyindole-3-carbaldehyde (4), -indole-3-acetonitrile (5), -tryptamine (6) , and -N,N-dimethyltryptamine (7) as useful synthetic intermediates.
In this paper, we wish to report about the success in the preparations of analogs of 1a as shown in a general formula 8, and also bromine derivatives of 4, 5, and 7.
Syntheses of 5-and 7-Formyl-4-hydroxy-N,N-dimethyltryptamines from Psilocin As psilocin analogs and key intermediates for further structural manipulations, we needed 5-formyl-(9, 5-formylpsilocin, Chart 2) and 7-formyl-4-hydroxy-N,N-dimethyltryptamine (10, 7-formylpsilocin) . With 1a in hand, its Vilsmeier reaction with N,N-dimethylformamide (DMF) and phosphorus oxychloride (POCl 3 ) was carried out to afford 9 as an unstable oil and 10 as stable crystals in varied yields, depending on the reaction conditions. Typical results are summarized in Table 1 .
To our surprise, in all cases (entries 1-4), significant amount of unreacted starting material was recovered in spite of employing excess amount of Vilsmeier reagent (5-10 mol eq). For this reason, the yields of 9 and 10 are low within the range of 17-31% and 11-13%, respectively. When the reaction temperature was raised from room temperature to 58°C (entry 5), the yield of 10 was slightly improved to 26%, while the recovery of 1a was still observed. Another interesting finding is that the yield of 9 seems to be almost constant irrespective of the examined reaction conditions (entries [2] [3] [4] [5] .
For the structural confirmations of 9 and 10, they were converted to 5-formyl-(11) and 7-formyl-1-tert-butoxycarbonyl-4-tert-butoxycarbonyloxy-N,N-dimethyltryptamine (12) in 78 and 66% yields, respectively, by treating with excess di-tert-butyl dicarbonate [(Boc) 2 
O] in the presence of 4-(dimethylamino)pyridine (DMAP).
Comparison of 1 H-NMR spectrum of 11 with that of 9 clearly shows that the C-7 proton signal of 11 resonated at lower magnetic field by ca. 1.3 ppm than that of 9. This anisotropy effect, caused by the Boc group introduced into the 1-position, proves that 9 and 11 are 5-formyl compounds. On the other hand, no anisotropic effect on the aromatic protons was observed in the cases of 10 and 12. Therefore, 10 and 12 are determined to be 7-formyl derivatives. Consequently, we have succeeded in the first syntheses of 5-formyl-(9) and 7-formylpsilocins (10) .
Syntheses of 5-and 7-Bromo-4-hydroxy-N,N-dimethyltryptamines from Psilocin We next attempted to introduce a bromine atom directly onto the benzene part of 1a for obtaining 5-bromo-(13, 5-bromopsilocin, Chart 3) and 7-bromo-4-hydroxy-N,N-dimethyltryptamines (14, 7-bromopsilocin). It is interesting to note that bromination of 1a with such reagents as Br 2 in AcOH, N-bromosuccinimide (NBS) in CHCl 3 , and pyridinium bromide perbromide (Py · HBr · Br 2 ) in CHCl 3 -Et 2 O, 7) did not occur. Under forced reaction conditions, only a small amount of brominated compounds were produced. Finally, we have found that bromination with Py · HBr · Br 2 proceeds in moderate yield in CH 2 Cl 2 containing a small amount of AcOH. As a result, an inseparable mixture of unstable 13 and 14 (in a ratio of 1 : 9), quite unstable 5,7-dibromo-4-hydroxytryptamine (15), and 1a were obtained in 44, 16, and 14% yields, respectively, by the reaction of 1a with Py · HBr · Br 2 (1.2 mol eq) in CH 2 Cl 2 -AcOH (10 : 1, v/v) at room temperature.
Acetylation of the mixture of 13 and 14 with Ac 2 O-pyridine produced readily separable 4-acetoxy-5-bromo-N,Ndimethyltryptamine (16) and 4-acetoxy-7-bromo-N,N-dimethyltryptamine (17) as stable compounds, respectively. Acetylation of 15 with the same reagent afforded stable 18.
Based on these findings, the isolation process of products was improved as follows. After bromination of 1a, the reaction mixture was subjected to column chromatography. Readily isolated unstable 15 and the mixture of 13 and 14 were immediately acetylated, separately. Consequently, 16-18 were obtained from 1a in 4, 34, and 14% overall yields, respectively. Alkaline hydrolysis of 16 with LiOH in MeOH provided 5-bromopsilocin (13) but the yield was 29% because of its unstable nature. Under the same reaction conditions, hydrolysis of 17 smoothly provided 7-bromopsilocin (14) in 82% yield. Preparations of Bromine Containing 4-Hydroxy-and 4-Benzyloxyindole-3-carbaldehydes, 4-Hydroxy-, and 4-Benzyloxyindole-3-acetonitriles Structure-activity relationship study requires a lot of compounds structurally related to the target compound. From this point of view, we next planned to prepare various 4-hydroxy-and 4-benzyloxyindole-3-carbaldehydes, and 4-hydroxy-and 4-benzyloxyindole-3-acetonitriles, having a bromine atom either at 5-or 7-Position (Chart 4).
Making use of synthetic intermediates involved in the pathway to 1a (Chart 1), we first examined bromination of 4 with Py · HBr · Br 2 in CHCl 3 -Et 2 O (1 : 1, v/v). 7) Regioselective introduction of a bromine atom into the 7-position was observed to give 4-benzyloxy-7-bromoindole-3-carbaldehyde (19) in 62% yield. Under similar reaction conditions, 5 provided a 63% yield of 4-benzyloxy-7-bromoindole-3-acetonitrile (20). The compound 20 was alternatively obtained in 74% yield directly from 19 together with a 17% yield of N-(4-benzyloxy-7-bromoindol-3-yl)methylformamide (21), by employing our reaction 8) using NaCN in the presence of NaBH 4 in NH 2 CHO-MeOH.
Bromination of 22, prepared by catalytic hydrogenation of 4 over 10% Pd-C in 76% yield, with Py · HBr · Br 2 in CHCl 3 -tetrahydrofuran (THF) (1 : 1, v/v) 9) provided 5-bromo-(23) and 7-bromo-4-hydroxyindole-3-carbaldehyde (24) in 10 and 84% yields, respectively. Treatments of 19 and 24 with an excess amount of benzyl bromide and K 2 CO 3 in DMF afforded the same 1-benzyl-4-benzyloxy-7-bromoindole-3-carbaldehyde (25) in 98 and 93% yields, respectively.
In order to attain regioselective bromination at the 5-position, an attempt was made by putting a sterically bulky group onto the 1-position. The reaction of 22 with (Boc) 2 O (1 mol eq) in CH 2 Cl 2 in the presence of Et 3 N and N,N-dimethylaminopyridine (DMAP) gave 1-tert-butoxycarbonyl-4-hydroxyindole-3-carbaldehyde (26) in 97% yield. The introduction of Boc group into the 1-position instead of the phenolic oxygen is confirmed by the following reactions; 1) treatment of 26 with benzyl bromide and KO-tert-Bu in DMF afforded 27 in 63% yield, 2) subsequent hydrolysis of 27 with NaOH in MeOH produced 4 in a quantitative yield.
As the structure of 26 was established, its bromination was examined with Py · HBr · Br 2 in CHCl 3 -THF (1 : 1, v/v). As expected, 5-bromo-1-tert-butoxycarbonyl-4-hydroxyindole-3-carbaldehyde (28) was produced as a sole product in 85% yield. Removal of Boc group in 28 with NaOH in MeOH gave a 93% yield of 23, which was identical with the sample obtained by bromination of 22. Comparison of 1 H-NMR spectra of 23 and 28 clearly shows an anisotropy effect of the Boc group on the C-7 proton by about 0.6 ppm, proving that these are 5-brominated compounds.
Further structural confirmations were obtained in the process of preparing 4-benzyloxy-5-bromoindole-3-carbaldehyde (30) and -acetonitrile (31) from 28. Thus, the compound 28 was converted to 4-benzyloxy-5-bromo-1-tert-butoxycarbonylindole-3-carbaldehyde (29) in 98% yield by the reaction with benzyl bromide and K 2 CO 3 . Subsequent hydrolysis of 29 with NaOH in MeOH afforded 30 in 97% yield. Treatment of 30 with NaCN in the presence of NaBH 4 in NH 2 CHO-MeOH 8) afforded 31 in 97% yield. Bromine Containing Derivatives of 7 and Another Synthetic Approach to 5-and 7-Bromopsilocin With the compound 7 in hand, we next tried to produce its bromine containing derivatives, and to find another synthetic approach to 5-(13) and 7-bromopsilocin (14) (Chart 5).
Bromination of 7 with Py · HBr · Br 2 in CHCl 3 -Et 2 O (1 : 1, v/v) provided 4-benzyloxy-7-bromo-N,N-dimethyltryptamine (32) in 31% yield. Attempts to improve the yield were made by employing Br 2 in AcOH and NBS in CHCl 3 under various reaction conditions in vain. Use of the HBr salt of 7 as a substrate was unsuccessful, either, under the same reaction conditions. Subsequent catalytic hydrogenation of 32 over 10% Pd-C in MeOH completely removed the bromine atom and produced 1a in almost quantitative yield. However, BBr 3 was found to be the reagent of choice for debenzylation. As a result, 7-bromopsilocin (14) was obtained in 41% yield.
The compound 32 could also be prepared in an alternative route. Reduction of 20 with LiAlH 4 in Et 2 O afforded 4-benzyloxy-7-bromotryptamine (33) in 86% yield together with a 11% yield of 6.
5) Subsequent dimethylation of 33 with (38) in 87% yield, just as observed in the bromination of 26. Finally, deprotection of the Boc group of 38 with CF 3 COOH furnished 5-bromopsilocin (13) in 97% yield. Thus, preparation of relatively unstable 13 by this route is far better than the direct bromination of 1a as described above.
Both N-and O-protected bromopsilocin would be a good synthetic intermediate for future use. So, we prepared 4-benzyloxy-7-bromo-1-tert-butoxycarbonyl-N,N-dimethyltryptamine (34) in 83% yield by treating 32 with (Boc) 2 O in CH 2 Cl 2 in the presence of DMAP. The other isomer, 4-benzyloxy-5-bromo-1-tert-butoxycarbonyl-N,N-dimethyltryptamine (35) was obtained in 43% yield by benzylation of 38 using KH and benzylbromide in DMF.
In conclusion, we have succeeded for the first time in developing synthetic methods for psilocin analogs having either a formyl group (9) (10) (11) (12) or bromine atom (13-18) at the 5-or 7-position. Preparations of 5-and 7-bromo derivatives of 4-hydroxy-(23, 24, 28) and 4-benzyloxyindole-3-carbaldehydes (19, 25, 29, 30), 4-benzyloxyindole-3-acetonitriles (20, 31), and 4-benzyloxy-N,N-dimethyltryptamines (32, 34, 35) have also been established. These compounds would be suitable for further manipulations. Biological evaluations of new compounds described in this paper are in progress.
Experimental
Melting points were determined on a Yanagimoto micro melting point apparatus and are uncorrected. IR spectra were determined with a Shimadzu IR-420 or Horiba FT-720 spectrophotometer, and 1 H-NMR spectra with a JEOL GSX-500 spectrometer, with tetramethylsilane as an internal standard. MS spectra were recorded on a JEOL SX-102A or JEOL JMS-GCmate spectrometer. Column chromatography was performed on silica gel (SiO 2 , 100-200 mesh, from Kanto Chemical Co., Inc.). Preparative thin layer chromatography (p-TLC) was performed on Merck Kiesel-gel GF 254 (type 60) (SiO 2 ).
5-Formyl-4-hydroxy-N,N-dimethyltryptamine (9) and 7-Formyl-4-hydroxy-N,N-dimethyltryptamine (10) from Psilocin (1a) Entry 1: Anhydrous DMF (1 ml) was added to an ice-cooled POCl 3 (91.0 mg, 0.59 mmol) and the mixture was stirred for 10 min at room temperature. To the resulting viscous solution was added a solution of 1a (22.4 mg, 0.11 mmol) in anhydrous DMF (2 ml) and stirring was continued for 14 h at room temperature. The reaction mixture was made basic by adding 2 N NaOH at 0°C and the whole was stirred at room temperature for 1 h. After adjusting pH to 7-8 with 1 N HCl, the whole was extracted with CHCl 3 -MeOH (95 : 5, v/v). The extract was washed with brine, dried over Na 2 SO 4 , and evaporated under reduced pressure to leave an oil, which was column-chromatographed on SiO 2 with CHCl 3 -MeOH-28% aq. NH 3 (46 : 5 : 0.5, v/v) to give 10 (2.8 mg, 11%), unreacted 1a (10.6 mg, 47%), and 9 (4.2 mg, 17%) in the order of elution. Entry 2: Anhydrous DMF (1 ml) was added to an ice-cooled POCl 3 (95.6 mg, 0.62 mmol) and the mixture was stirred for 10 min at room temperature. To the resulting viscous solution was added a solution of 1a (19.0 mg, 0.093 mmol) in anhydrous DMF (2 ml) and stirring was continued for 23 h at room temperature. After work-up and purification as described in entry 1, 10 (2.9 mg, 13%), unreacted 1a (8.8 mg, 46%), and 9 (6.2 mg, 29%) were obtained in the order of elution.
Entry 3: Anhydrous DMF (1 ml) was added to an ice-cooled POCl 3 (102.4 mg, 0.67 mmol) and the mixture was stirred for 10 min at room temperature. To the resulting viscous solution was added a solution of 1a (21.4 mg, 0.11 mmol) in anhydrous DMF (2 ml) and stirring was continued for 72 h at room temperature. After work-up and purification as described in entry 1, 10 (2.6 mg, 11%), unreacted 1a (6.4 mg, 30%), and 9 (7.5 mg, 31%) were obtained in the order of elution.
Entry 4: Anhydrous DMF (1 ml) was added to an ice-cooled POCl 3
Chart 5
(170.8 mg, 1.11 mmol) and the mixture was stirred for 10 min at room temperature. To the resulting viscous solution was added a solution of 1a (21.2 mg, 0.10 mmol) in anhydrous DMF (2 ml) and stirring was continued for 95 h at room temperature. After work-up and purification as described in entry 1, 10 (3.0 mg, 12%), unreacted 1a (8.5 mg, 40%), and 9 (6.4 mg, 27%) were obtained in the order of elution. Entry 5: Anhydrous DMF (1 ml) was added to an ice-cooled POCl 3 (96.4 mg, 0.62 mmol) and the mixture was stirred for 10 min at room temperature. To the resulting viscous solution was added a solution of 1a (21.6 mg, 0.11 mmol) in anhydrous DMF (2 ml) and stirring was continued for 23 h at 58°C. After work-up and purification as described in entry 1, 10 (6.4 mg, 26%), unreacted 1a (6.2 mg, 29%), and 9 (6.8 mg, 28%) were obtained in the order of elution.
1-tert-Butoxycarbonyl-4-tert-butoxycarbonyloxy-5-formyl-N,N-dimethyltryptamine (11) from 9 A solution of 9 (10.4 mg, 0.045 mmol), DMAP (5.6 mg, 0.046 mmol), and Boc 2 O (0.04 ml, 0.17 mmol) in CH 2 11) (42.2 mg, 0.13 mmol) was added to a solution of 1a (22.4 mg, 0.11 mmol) in CH 2 Cl 2 (3 ml) and AcOH (0.3 ml), and the mixture was stirred at room temperature for 5 h. After evaporation of the solvent under reduced pressure, the residue was column-chromatographed repeatedly on SiO 2 with CHCl 3 -MeOH-28% aq. NH 3 (46 : 5 : 0.5, v/v) to give quite unstable 15 (6.3 mg, 16%), a mixture (13.8 mg, 44%) of unstable 13 and 14 (in a ratio of 1 : 9, calculated by 1 H-NMR) and unreacted 1a (3.1 mg, 14%) in the order of elution. Compound 15 was so unstable that spectral data of pure sample were not obtained. Ac 2 O (1 ml) was added to a solution of the mixture of 13 and 14 (13.8 mg) in pyridine (2 ml), and the mixture was stirred at room temperature for 23 h. After evaporation of the solvent under reduced pressure, the residue was column-chromatographed repeatedly on SiO 2 with CHCl 3 -MeOH-28% aq. NH 3 Compound 20 and N-(4-Benzyloxy-7-bromoindol-3-yl)methylformamide (21) from 19 NaBH 4 (3.5 mg, 0.092 mmol) was added to a solution of 19 (18.6 mg, 0.056 mmol) in NH 2 CHO-MeOH (1 : 1, v/v, 4 ml), and the mixture was stirred for 0.5 h. To the reaction mixture was added NaCN (30.2 mg, 0.62 mmol) and the whole was refluxed on oil bath at 100°C for 3 h with stirring. After cooling to room temperature, brine was added and the whole was extracted with CHCl 3 . The extract was washed with brine, dried over Na 2 SO 4 , and evaporated under reduced pressure to leave an oil, which was column-chromatographed on SiO 2 to give 20 (14. 4-Hydroxyindole-3-carbaldehyde (22) from 4 A suspension of 4 (187.1 mg, 0.75 mmol) and 10% Pd-C (82.0 mg) in MeOH (15 ml) was stirred at room temperature for 1 h under H 2 atmosphere. The reaction mixture was filtered through SiO 2 to remove Pd-C and the filtrate was evaporated under reduced pressure to leave a crystalline solid, which was recrystallized from CHCl 3 -MeOH to give 22 (70.6 mg). The mother liquor was purified by p-TLC on SiO 2 , and the mixture was stirred at room temperature for 24 h. After addition of brine, the whole was extracted with AcOEt. The extract was washed with brine, dried over Na 2 SO 4 , and evaporated under reduced pressure to leave a crystalline solid, which was column-chromatographed on SiO 2 with CHCl 3 -hexane (7 : 3, v/v) Compound 25 from 24 A solution of benzyl bromide (64.1 mg, 0.38 mmol) in DMF (1 ml) was added to a suspension of 24 (16.0 mg, 0.067 mmol) and K 2 CO 3 (29.8 mg, 0.22 mmol) in DMF (1 ml), and the mixture was stirred at room temperature for 24 h. After addition of brine, the whole was extracted with AcOEt. The extract was washed with brine, dried over Na 2 SO 4 , and evaporated under reduced pressure to leave a crystalline solid, which was column-chromatographed on SiO 2 with CHCl 3 -hexane (1 : 1, v/v) to give 25 (26.1 mg, 93%).
4-Benzyloxy-7-bromoindole-3-carbaldehyde (19) from 4-Benzyloxyindole-3-carbaldehyde (4)
1-tert-Butoxycarbonyl-4-hydroxyindole-3-carbaldehyde (26) from 22 DMAP (14.3 mg, 0.12 mmol) and a solution of Boc 2 O (134.8 mg, 0.62 mmol) in CH 2 Cl 2 (2 ml) were successively added to a solution of 22 (98.0 mg, 0.61 mmol) in CH 2 Cl 2 -Et 3 N (9 : 1, v/v, 10 ml), and the mixture was stirred at room temperature for 2 h. The reaction mixture was evaporated under reduced pressure to leave a crystalline solid, which was column-chromatographed on SiO 2 with CHCl 3 -hexane Compound 4 from 27 A solution of NaOH (17.9 mg, 0.45 mmol) in MeOH (0.6 ml) was added to a solution of 27 (26.4 mg, 0.075 mmol) in MeOH (2 ml), and the mixture was stirred for 2 h at room temperature. Saturated NH 4 Cl solution was added and the whole was extracted with AcOEt. The extract was washed with brine, dried over Na 2 SO 4 , and evaporated under reduced pressure to leave a crystalline solid, which was column-chromatographed on SiO 2 Compound 23 from 28 A solution of NaOH (10.2 mg, 0.23 mmol) in MeOH (0.5 ml) was added to a solution of 28 (10.7 mg, 0.031 mmol) in MeOH (2 ml), and the mixture was stirred for 2.5 h at room temperature. Saturated NH 4 Cl solution was added and the whole was extracted with AcOEt. The extract was washed with brine, dried over Na 2 SO 4 , and evaporated under reduced pressure to leave a crystalline solid, which was columnchromatographed on SiO 2 with AcOEt-hexane (1 : 1, v/v) to give 23 (7.1 mg, 93%).
4-Benzyloxy-5-bromo-1-tert-butoxycarbonylindole-3-carbaldehyde (29) from 28 KO-tert-Bu (24.5 mg, 0.22 mmol) was added to a solution of 28 (36.2 mg, 0.11 mmol) in anhydrous DMF (2 ml) at 0°C, and the mixture was stirred at 0°C for 10 min. To this orange solution was added a solution of benzyl bromide (36.3 mg, 0.21 mmol) in anhydrous DMF (1 ml) and stirring was continued at room temperature for 1 h. Saturated NH 4 Cl solution was added and the whole was extracted with AcOEt. The extract was washed with brine, dried over Na 2 SO 4 , and evaporated under reduced pressure to leave a crystalline solid, which was column-chromatographed on SiO 2 with AcOEt-hexane (1 : 4, v/v) to give 29 (44.9 mg, 98% 4-Benzyloxy-5-bromoindole-3-carbaldehyde (30) from 29 A solution of NaOH (161.8 mg, 4.05 mmol) in MeOH (10 ml) was added to a solution of 29 (288.8 mg, 0.67 mmol) in MeOH (20 ml), and the mixture was stirred at room temperature for 2 h. Saturated NH 4 Cl solution was added and the whole was extracted with AcOEt. The extract was washed with brine, dried over Na 2 SO 4 , and evaporated under reduced pressure to leave a crystalline solid, which was recrystallized from MeOH to give 30 (141.2 mg) as colorless needles. 2 CHO-MeOH (1 : 1, v/v, 4 ml), and the mixture was stirred at room temperature for 0.5 h. To the reaction mixture was added NaCN (52.8 mg, 1.08 mmol) and the whole was refluxed on oil bath at 100°C for 2 h with stirring. After cooling to room temperature, brine was added and the whole was extracted with CHCl 3 . The extract was washed with brine, dried over Na 2 SO 4 , and evaporated under reduced pressure to leave an oil, which was column-chromatographed on SiO 2 
